Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis

Background and objective Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical proper...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respirology (Carlton, Vic.) Vic.), 2018-08, Vol.23 (8), p.764-770
Hauptverfasser: Nyilas, Sylvia, Schreder, Theresa, Singer, Florian, Poellinger, Alexander, Geiser, Thomas Kurt, Latzin, Philipp, Funke, Manuela
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 770
container_issue 8
container_start_page 764
container_title Respirology (Carlton, Vic.)
container_volume 23
creator Nyilas, Sylvia
Schreder, Theresa
Singer, Florian
Poellinger, Alexander
Geiser, Thomas Kurt
Latzin, Philipp
Funke, Manuela
description Background and objective Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N2‐MBW in IPF. Methods In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N2‐MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), bronchiectasis score from computed tomography scans, the Gender–Age–Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage. Results All patients were able to perform N2‐MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1–13.8) in IPF versus 7.3 (6.9–8.4) in controls (P < 0.0001). LCI correlated with DLCO corrected for haemoglobin (corrDLCO; r = −0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow‐up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population. Conclusion N2‐MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality. In this pilot study, we demonstrate that nitrogen‐multiple breath washout (N2‐MBW) is a feasible, sensitive and reproducible lung function test in patients with idiopathic pulmonary fibrosis. The N2‐MBW‐derived lung clearance index correlates with clinical disease severity, structural airway pathology and mortality. See related Editorial
doi_str_mv 10.1111/resp.13294
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2018028423</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2069955626</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3934-5037b2c2cc65eb7c89a6ecfb91bbaf0044b72f314bd54ebdcbc299a81443e6103</originalsourceid><addsrcrecordid>eNp9kUlLLDEUhYM8cd74Ax6BtxGhNFMNcdeIEyiKw7pIUik7Up2USYXGf-_V1rdwYRbJJXwczrkHoX1Kjiic42jTeEQ5k2INbVEhSEEbwf_AzBkv6lrKTbSd0gshhJek3ECbTJY1jHILhZs8TG4cLNbRqmmOlyrNQ55O8Ax7u8TKd3iMYeGS8894yHD12ZvJBY8nmybch4hHNTnrp4SXDhRc5wL8zJ3BYx4Wwav4hnunY0gu7aL1Xg3J7n29O-jp_Ozx9LK4vr24Op1dF4ZLLoqS8Fozw4ypSqtr00hVWdNrSbVWPSFC6Jr1nArdlcLqzmjDpFQNpOe2ooTvoIOVLph_zWC0hQjGDoPyNuTUMkIbwhrBOKD_fqAvIUcP7oCqpCzLilVAHa4oAzlStH07RreAaC0l7UcN7UcN7WcNAP_9ksx6Ybv_6PfeAaArYOkG-_aLVHt_9nC3En0H1eCUYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2069955626</pqid></control><display><type>article</type><title>Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Nyilas, Sylvia ; Schreder, Theresa ; Singer, Florian ; Poellinger, Alexander ; Geiser, Thomas Kurt ; Latzin, Philipp ; Funke, Manuela</creator><creatorcontrib>Nyilas, Sylvia ; Schreder, Theresa ; Singer, Florian ; Poellinger, Alexander ; Geiser, Thomas Kurt ; Latzin, Philipp ; Funke, Manuela</creatorcontrib><description>Background and objective Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N2‐MBW in IPF. Methods In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N2‐MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), bronchiectasis score from computed tomography scans, the Gender–Age–Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage. Results All patients were able to perform N2‐MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1–13.8) in IPF versus 7.3 (6.9–8.4) in controls (P &lt; 0.0001). LCI correlated with DLCO corrected for haemoglobin (corrDLCO; r = −0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow‐up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population. Conclusion N2‐MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality. In this pilot study, we demonstrate that nitrogen‐multiple breath washout (N2‐MBW) is a feasible, sensitive and reproducible lung function test in patients with idiopathic pulmonary fibrosis. The N2‐MBW‐derived lung clearance index correlates with clinical disease severity, structural airway pathology and mortality. See related Editorial</description><identifier>ISSN: 1323-7799</identifier><identifier>EISSN: 1440-1843</identifier><identifier>DOI: 10.1111/resp.13294</identifier><identifier>PMID: 29573509</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Adult ; Aged ; Breath Tests ; Bronchiectasis ; Bronchiectasis - diagnostic imaging ; Carbon Monoxide ; Computed tomography ; Feasibility studies ; Female ; Fibrosis ; Hemoglobin ; Humans ; idiopathic pulmonary fibrosis ; Idiopathic Pulmonary Fibrosis - physiopathology ; Idiopathic Pulmonary Fibrosis - surgery ; interstitial lung disease ; lung clearance index ; Lung diseases ; lung fibrosis ; Lung Transplantation ; Male ; Middle Aged ; multiple breath washout ; Nitrogen ; Parenchyma ; Pilot Projects ; Prospective Studies ; Pulmonary Diffusing Capacity ; Pulmonary fibrosis ; Pulmonary Ventilation ; Reproducibility of Results ; Respiratory diseases ; Respiratory function ; Respiratory tract diseases ; Severity of Illness Index ; Tidal Volume ; Tomography, X-Ray Computed ; Vital Capacity ; Young Adult</subject><ispartof>Respirology (Carlton, Vic.), 2018-08, Vol.23 (8), p.764-770</ispartof><rights>2018 Asian Pacific Society of Respirology</rights><rights>2018 Asian Pacific Society of Respirology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3934-5037b2c2cc65eb7c89a6ecfb91bbaf0044b72f314bd54ebdcbc299a81443e6103</citedby><cites>FETCH-LOGICAL-c3934-5037b2c2cc65eb7c89a6ecfb91bbaf0044b72f314bd54ebdcbc299a81443e6103</cites><orcidid>0000-0003-1840-3118</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fresp.13294$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fresp.13294$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29573509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nyilas, Sylvia</creatorcontrib><creatorcontrib>Schreder, Theresa</creatorcontrib><creatorcontrib>Singer, Florian</creatorcontrib><creatorcontrib>Poellinger, Alexander</creatorcontrib><creatorcontrib>Geiser, Thomas Kurt</creatorcontrib><creatorcontrib>Latzin, Philipp</creatorcontrib><creatorcontrib>Funke, Manuela</creatorcontrib><title>Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis</title><title>Respirology (Carlton, Vic.)</title><addtitle>Respirology</addtitle><description>Background and objective Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N2‐MBW in IPF. Methods In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N2‐MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), bronchiectasis score from computed tomography scans, the Gender–Age–Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage. Results All patients were able to perform N2‐MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1–13.8) in IPF versus 7.3 (6.9–8.4) in controls (P &lt; 0.0001). LCI correlated with DLCO corrected for haemoglobin (corrDLCO; r = −0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow‐up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population. Conclusion N2‐MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality. In this pilot study, we demonstrate that nitrogen‐multiple breath washout (N2‐MBW) is a feasible, sensitive and reproducible lung function test in patients with idiopathic pulmonary fibrosis. The N2‐MBW‐derived lung clearance index correlates with clinical disease severity, structural airway pathology and mortality. See related Editorial</description><subject>Adult</subject><subject>Aged</subject><subject>Breath Tests</subject><subject>Bronchiectasis</subject><subject>Bronchiectasis - diagnostic imaging</subject><subject>Carbon Monoxide</subject><subject>Computed tomography</subject><subject>Feasibility studies</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>idiopathic pulmonary fibrosis</subject><subject>Idiopathic Pulmonary Fibrosis - physiopathology</subject><subject>Idiopathic Pulmonary Fibrosis - surgery</subject><subject>interstitial lung disease</subject><subject>lung clearance index</subject><subject>Lung diseases</subject><subject>lung fibrosis</subject><subject>Lung Transplantation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>multiple breath washout</subject><subject>Nitrogen</subject><subject>Parenchyma</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Pulmonary Diffusing Capacity</subject><subject>Pulmonary fibrosis</subject><subject>Pulmonary Ventilation</subject><subject>Reproducibility of Results</subject><subject>Respiratory diseases</subject><subject>Respiratory function</subject><subject>Respiratory tract diseases</subject><subject>Severity of Illness Index</subject><subject>Tidal Volume</subject><subject>Tomography, X-Ray Computed</subject><subject>Vital Capacity</subject><subject>Young Adult</subject><issn>1323-7799</issn><issn>1440-1843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUlLLDEUhYM8cd74Ax6BtxGhNFMNcdeIEyiKw7pIUik7Up2USYXGf-_V1rdwYRbJJXwczrkHoX1Kjiic42jTeEQ5k2INbVEhSEEbwf_AzBkv6lrKTbSd0gshhJek3ECbTJY1jHILhZs8TG4cLNbRqmmOlyrNQ55O8Ax7u8TKd3iMYeGS8894yHD12ZvJBY8nmybch4hHNTnrp4SXDhRc5wL8zJ3BYx4Wwav4hnunY0gu7aL1Xg3J7n29O-jp_Ozx9LK4vr24Op1dF4ZLLoqS8Fozw4ypSqtr00hVWdNrSbVWPSFC6Jr1nArdlcLqzmjDpFQNpOe2ooTvoIOVLph_zWC0hQjGDoPyNuTUMkIbwhrBOKD_fqAvIUcP7oCqpCzLilVAHa4oAzlStH07RreAaC0l7UcN7UcN7WcNAP_9ksx6Ybv_6PfeAaArYOkG-_aLVHt_9nC3En0H1eCUYA</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Nyilas, Sylvia</creator><creator>Schreder, Theresa</creator><creator>Singer, Florian</creator><creator>Poellinger, Alexander</creator><creator>Geiser, Thomas Kurt</creator><creator>Latzin, Philipp</creator><creator>Funke, Manuela</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1840-3118</orcidid></search><sort><creationdate>201808</creationdate><title>Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis</title><author>Nyilas, Sylvia ; Schreder, Theresa ; Singer, Florian ; Poellinger, Alexander ; Geiser, Thomas Kurt ; Latzin, Philipp ; Funke, Manuela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3934-5037b2c2cc65eb7c89a6ecfb91bbaf0044b72f314bd54ebdcbc299a81443e6103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Breath Tests</topic><topic>Bronchiectasis</topic><topic>Bronchiectasis - diagnostic imaging</topic><topic>Carbon Monoxide</topic><topic>Computed tomography</topic><topic>Feasibility studies</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>idiopathic pulmonary fibrosis</topic><topic>Idiopathic Pulmonary Fibrosis - physiopathology</topic><topic>Idiopathic Pulmonary Fibrosis - surgery</topic><topic>interstitial lung disease</topic><topic>lung clearance index</topic><topic>Lung diseases</topic><topic>lung fibrosis</topic><topic>Lung Transplantation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>multiple breath washout</topic><topic>Nitrogen</topic><topic>Parenchyma</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Pulmonary Diffusing Capacity</topic><topic>Pulmonary fibrosis</topic><topic>Pulmonary Ventilation</topic><topic>Reproducibility of Results</topic><topic>Respiratory diseases</topic><topic>Respiratory function</topic><topic>Respiratory tract diseases</topic><topic>Severity of Illness Index</topic><topic>Tidal Volume</topic><topic>Tomography, X-Ray Computed</topic><topic>Vital Capacity</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nyilas, Sylvia</creatorcontrib><creatorcontrib>Schreder, Theresa</creatorcontrib><creatorcontrib>Singer, Florian</creatorcontrib><creatorcontrib>Poellinger, Alexander</creatorcontrib><creatorcontrib>Geiser, Thomas Kurt</creatorcontrib><creatorcontrib>Latzin, Philipp</creatorcontrib><creatorcontrib>Funke, Manuela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Respirology (Carlton, Vic.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nyilas, Sylvia</au><au>Schreder, Theresa</au><au>Singer, Florian</au><au>Poellinger, Alexander</au><au>Geiser, Thomas Kurt</au><au>Latzin, Philipp</au><au>Funke, Manuela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis</atitle><jtitle>Respirology (Carlton, Vic.)</jtitle><addtitle>Respirology</addtitle><date>2018-08</date><risdate>2018</risdate><volume>23</volume><issue>8</issue><spage>764</spage><epage>770</epage><pages>764-770</pages><issn>1323-7799</issn><eissn>1440-1843</eissn><abstract>Background and objective Idiopathic pulmonary fibrosis (IPF) is a devastating progressive lung disease affecting the parenchyma. Nitrogen multiple‐breath washout (N2‐MBW) is a lung function test that measures ventilation inhomogeneity, a biomarker of small airway disease. We assessed clinical properties of N2‐MBW in IPF. Methods In this prospective cohort pilot study, 25 IPF patients and 25 healthy controls were assessed at baseline and 10 patients at median 6.2 months later. Outcomes included the lung clearance index (LCI) from N2‐MBW, forced vital capacity (FVC) from spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), bronchiectasis score from computed tomography scans, the Gender–Age–Physiology (GAP score for IPF) stage and death or lung transplantation (LTx). Study end points were feasibility, repeatability, discriminative capacity and correlation with disease severity and structural lung damage. Results All patients were able to perform N2‐MBW. LCI was repeatable and reproducible. Median (interquartile range (IQR)) LCI in IPF was 11.6 (10.1–13.8) in IPF versus 7.3 (6.9–8.4) in controls (P &lt; 0.0001). LCI correlated with DLCO corrected for haemoglobin (corrDLCO; r = −0.49, P = 0.016), bronchiectasis score (r = 0.45, P = 0.024) and the GAP stage (r = 0.59, P = 0.002), but not with FVC. FVC was not related to bronchiectasis. During follow‐up, six patients died and one received LTx. LCI correlated with the latter compound outcome: hazard ratio (95% CI) was 2.43 (1.26; 4.69) per one LCI SD from the patient population. Conclusion N2‐MBW is a feasible, reliable and valid lung function test in IPF. LCI correlates with diffusion impairment, structural airway damage and clinical disease severity. LCI is a promising surveillance tool in IPF that may predict mortality. In this pilot study, we demonstrate that nitrogen‐multiple breath washout (N2‐MBW) is a feasible, sensitive and reproducible lung function test in patients with idiopathic pulmonary fibrosis. The N2‐MBW‐derived lung clearance index correlates with clinical disease severity, structural airway pathology and mortality. See related Editorial</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>29573509</pmid><doi>10.1111/resp.13294</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-1840-3118</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1323-7799
ispartof Respirology (Carlton, Vic.), 2018-08, Vol.23 (8), p.764-770
issn 1323-7799
1440-1843
language eng
recordid cdi_proquest_miscellaneous_2018028423
source MEDLINE; Wiley Online Library All Journals
subjects Adult
Aged
Breath Tests
Bronchiectasis
Bronchiectasis - diagnostic imaging
Carbon Monoxide
Computed tomography
Feasibility studies
Female
Fibrosis
Hemoglobin
Humans
idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis - physiopathology
Idiopathic Pulmonary Fibrosis - surgery
interstitial lung disease
lung clearance index
Lung diseases
lung fibrosis
Lung Transplantation
Male
Middle Aged
multiple breath washout
Nitrogen
Parenchyma
Pilot Projects
Prospective Studies
Pulmonary Diffusing Capacity
Pulmonary fibrosis
Pulmonary Ventilation
Reproducibility of Results
Respiratory diseases
Respiratory function
Respiratory tract diseases
Severity of Illness Index
Tidal Volume
Tomography, X-Ray Computed
Vital Capacity
Young Adult
title Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A49%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20breath%20washout:%20A%20new%20and%20promising%20lung%20function%20test%20for%20patients%20with%20idiopathic%20pulmonary%20fibrosis&rft.jtitle=Respirology%20(Carlton,%20Vic.)&rft.au=Nyilas,%20Sylvia&rft.date=2018-08&rft.volume=23&rft.issue=8&rft.spage=764&rft.epage=770&rft.pages=764-770&rft.issn=1323-7799&rft.eissn=1440-1843&rft_id=info:doi/10.1111/resp.13294&rft_dat=%3Cproquest_cross%3E2069955626%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2069955626&rft_id=info:pmid/29573509&rfr_iscdi=true